Whole-Body Hyperthermia vs Local Hyperthermia: Understanding the Differences

What Is Medical Hyperthermia?

Medical hyperthermia — the controlled therapeutic application of heat — is one of the oldest treatment principles in medicine. Hippocrates observed that fever could cure disease, and modern hyperthermia harnesses this principle with precision engineering, real-time temperature monitoring, and decades of clinical research. Today, hyperthermia is used in oncology, infectious disease, chronic pain, and immune modulation at specialized medical centers worldwide.

At St. George Hospital in Bad Aibling, Germany, hyperthermia has been a cornerstone of our treatment approach for over three decades. The late Prof. Dr. Friedrich Douwes was among the pioneers of clinical hyperthermia in Europe, establishing our hospital as one of the continent’s leading hyperthermia centers. Today, Dr. Julian Douwes and our medical team continue this legacy, applying both whole-body and local hyperthermia across our oncology, infectious disease, and integrative medicine programs.

But whole-body hyperthermia and local hyperthermia are fundamentally different treatments — different in mechanism, temperature range, indication, equipment, and clinical effect. Understanding these differences is essential for patients considering hyperthermia therapy and for physicians seeking to refer patients appropriately.

Whole-Body Hyperthermia: Systemic Thermal Treatment

How Whole-Body Hyperthermia Works

Whole-body hyperthermia (WBH) raises the entire body’s core temperature in a controlled, medically supervised manner — effectively inducing a therapeutic fever. The patient lies in a specially designed treatment unit that applies infrared-A radiation to the body surface, gradually elevating core temperature over 60–90 minutes.

Temperature Ranges

Whole-body hyperthermia operates at two primary temperature levels:

Moderate Whole-Body Hyperthermia (38.5–40.5°C / 101.3–104.9°F)

• Also called fever-range WBH
• Mimics the body’s natural fever response
• Treatment duration: 60–90 minutes at target temperature
• Well-tolerated by most patients
• Primary applications: immune activation, infectious disease, chronic pain, chronic fatigue

Extreme Whole-Body Hyperthermia (41.5–42.0°C / 106.7–107.6°F)

• Also called high-dose WBH
• Requires sedation and intensive monitoring
• Treatment duration: 60 minutes at target temperature
• Reserved for specific oncological indications
• Direct cytotoxic effect on cancer cells combined with immune activation

Equipment

At St. George Hospital, we use the Heckel HT-3000 system — one of the most advanced whole-body hyperthermia devices available. This system provides:

• Water-filtered infrared-A radiation for even, deep heating
• Continuous core temperature monitoring via rectal probe
• Integrated vital sign monitoring (heart rate, blood pressure, oxygen saturation)
• Precise temperature control with programmable heating curves
• Patient comfort features including cool head support

Biological Mechanisms of Whole-Body Hyperthermia

The therapeutic effects of WBH are multifaceted:

Immune Activation

• Natural killer cell activation — fever-range temperatures increase NK cell cytotoxicity by 50–100%, as documented in research published in the International Journal of Hyperthermia
• Dendritic cell maturation — enhancing antigen presentation and adaptive immune response
• Heat shock protein expression — HSPs (particularly HSP70) serve as danger signals that alert the immune system to damaged or infected cells
• Cytokine modulation — shifting from chronic inflammatory patterns toward acute immune activation

Anti-Infectious Effects

• Direct thermal stress on heat-sensitive pathogens — Borrelia burgdorferi, for example, does not thrive at elevated temperatures
• Enhanced penetration of antimicrobial agents into infected tissues through increased blood flow
• Biofilm disruption — heat can destabilize the protective biofilms formed by chronic infections

Systemic Metabolic Effects

• Increased metabolic rate and circulation
• Enhanced detoxification through sweating and increased hepatic and renal blood flow
• Improved microcirculation
• Endorphin release — many patients report a sense of wellbeing following treatment

Clinical Indications for Whole-Body Hyperthermia

• Lyme disease and tick-borne infections — one of our most common applications
• Cancer — as an adjunct to chemotherapy and/or radiation (at extreme temperatures)
• Chronic fatigue syndrome — immune reset and mitochondrial stimulation
• Post-COVID syndrome — immune modulation and pathogen clearance
• Chronic pain conditions — fibromyalgia, rheumatoid disorders
• Depression — emerging research on WBH as an antidepressant intervention

Local Hyperthermia: Targeted Regional Treatment

How Local Hyperthermia Works

Local (or regional) hyperthermia heats a specific area of the body — typically a tumor or tumor region — to temperatures of 40–44°C (104–111.2°F) without significantly raising the overall body temperature. The heat is delivered directly to the target tissue using electromagnetic energy.

Temperature Ranges

• Mild local hyperthermia: 40–41°C — primarily for immune modulation and drug sensitization
• Moderate local hyperthermia: 41–43°C — standard oncological application, combining direct cytotoxicity with chemosensitization
• Thermal ablation: Above 43–45°C — directly destroying tissue (used in interventional radiology, distinct from hyperthermia in the traditional sense)

Equipment

St. George Hospital utilizes several local hyperthermia systems:

• Oncotherm EHY-2000 — modulated electro-hyperthermia (mEHT) that combines capacitive radiofrequency heating with amplitude modulation. This “smart” approach selectively heats tumor tissue due to its different electrical properties compared to healthy tissue
• BSD-2000 — deep regional hyperthermia system using phased-array antennas for tumors deep within the body (pelvis, abdomen)
• Superficial microwave applicators — for tumors at or near the body surface (breast, chest wall, skin)

Biological Mechanisms of Local Hyperthermia

Direct Tumor Cell Damage

• Protein denaturation in tumor cells at temperatures above 42°C
• Disruption of DNA repair mechanisms — preventing tumor cells from recovering from chemotherapy or radiation damage
• Cell membrane destabilization — increasing permeability to chemotherapeutic agents

Chemosensitization

One of the most clinically important effects of local hyperthermia is its ability to enhance the efficacy of chemotherapy. Research demonstrates that heat increases the cytotoxic effect of many chemotherapeutic agents by 1.5–10 times, depending on the drug and temperature achieved. This means that lower drug doses can achieve greater tumor kill — potentially reducing side effects while improving efficacy.

Radiosensitization

Heat and radiation are complementary: radiation is most effective against well-oxygenated cells in certain phases of the cell cycle, while heat preferentially damages hypoxic cells (which are typically radiation-resistant) and cells in phases where radiation is less effective. Combining the two modalities attacks the tumor from both angles.

Immune Effects

• Heat-induced tumor cell death (particularly immunogenic cell death) releases tumor antigens
• Local heat shock protein expression creates “danger signals” that recruit immune cells to the tumor
• Enhanced trafficking of immune cells into the heated tumor region
• Potential abscopal effect — immune activation at the treated site may trigger immune responses against untreated metastatic sites

Clinical Indications for Local Hyperthermia

• Solid tumors — breast, prostate, pancreatic, bladder, cervical, head and neck cancers
• Recurrent tumors — where standard treatments have been exhausted
• Chemotherapy enhancement — as an adjunct to concurrent systemic or regional chemotherapy
• Radiation enhancement — combined with radiotherapy for improved local control
• Palliative care — pain reduction in tumors invading nerve structures

Whole-Body vs Local Hyperthermia: A Direct Comparison

Scope of Treatment

Which Conditions Benefit from Which Type?

Choose Whole-Body Hyperthermia When:

• The condition is systemic — affecting the whole body (Lyme disease, chronic fatigue, post-COVID)
• Immune activation is the primary goal
• Multiple metastatic sites need to be addressed (systemic immune stimulation)
• The patient has a chronic infection that has disseminated through the body
• Depression or chronic pain with a systemic inflammatory component

Choose Local Hyperthermia When:

• A specific, localized tumor needs treatment
• The goal is to enhance chemotherapy or radiation at a defined target
• The tumor is accessible to electromagnetic heating devices
• The patient cannot tolerate the physiological stress of whole-body heating
• A targeted approach is sufficient for the clinical situation

Use Both in Combination When:

• Advanced cancer with both local and systemic disease — local hyperthermia targets the primary tumor while whole-body hyperthermia activates systemic immune responses
• Cancer patients with concurrent chronic infection (e.g., reactivated EBV in immunocompromised oncology patients)
• Patients who need both tumor-directed treatment and systemic immune restoration

Safety and Side Effects

Whole-Body Hyperthermia

Moderate WBH (38.5–40.5°C) is generally well-tolerated. Common effects include:

• Fatigue for 24–48 hours post-treatment
• Mild headache
• Temporary increase in heart rate during treatment
• Herxheimer reaction in infectious disease patients (die-off symptoms)

Contraindications include severe cardiovascular disease, uncontrolled epilepsy, pregnancy, and acute thrombosis.

Local Hyperthermia

Local hyperthermia has an excellent safety profile. Potential side effects are typically limited to:

• Skin redness or mild burns at the treatment site (uncommon with modern equipment)
• Localized discomfort or warmth during treatment
• Temporary swelling in the treated area

Our Hyperthermia Expertise at St. George Hospital

With over 30 years of clinical hyperthermia experience, St. George Hospital offers one of Europe’s most comprehensive hyperthermia programs. Our advantages include:

• Full spectrum of equipment — both whole-body (Heckel HT-3000) and local (Oncotherm, BSD) systems
• Multidisciplinary expertise — oncologists, infectious disease specialists, and integrative physicians working together
• Thousands of treatments performed — extensive clinical experience across oncology, Lyme disease, post-COVID, and chronic conditions
• Integration with complementary therapies — hyperthermia combined with ozone therapy, apheresis, NAD+ infusions, and targeted antimicrobials
• Research contribution — ongoing participation in hyperthermia research, building on the legacy of Prof. Dr. Friedrich Douwes

Frequently Asked Questions About Hyperthermia

Is whole-body hyperthermia painful?

No. Moderate whole-body hyperthermia feels similar to sitting in a hot sauna — progressively warm, with profuse sweating. The head remains outside the treatment unit and is kept cool. Most patients find the treatment tolerable and some find it relaxing. Medical staff monitor you continuously throughout the session. Extreme WBH (above 41°C) is performed under sedation, so the patient experiences no discomfort during the procedure.

How many hyperthermia sessions do I need?

This depends entirely on the condition being treated. For Lyme disease, patients typically receive two to three whole-body hyperthermia sessions during a two-to-three-week inpatient stay. For oncology patients, local hyperthermia may be administered twice weekly for several weeks alongside chemotherapy or radiation. Dr. Julian Douwes designs individual treatment plans based on your diagnosis, treatment response, and overall condition.

Can hyperthermia replace chemotherapy or antibiotics?

Hyperthermia is most effective as part of a multimodal treatment approach, not as a standalone replacement. In oncology, hyperthermia enhances the effects of chemotherapy and radiation — it does not replace them. In infectious disease, hyperthermia supports and amplifies the effects of antimicrobial therapy. The greatest clinical benefit comes from combining hyperthermia with other appropriate treatments.

Is hyperthermia covered by insurance?

In Germany, local hyperthermia for oncological indications is increasingly recognized by insurance providers, particularly for specific tumor types and clinical situations. Whole-body hyperthermia coverage varies by insurer and indication. Our international patient coordinators can provide guidance on documentation for insurance reimbursement claims in your country.

What is the difference between hyperthermia and sauna?

While both involve heat, medical hyperthermia differs fundamentally from sauna in precision, monitoring, and therapeutic intent. A sauna heats the skin surface and raises core temperature modestly (typically to 38–38.5°C). Medical hyperthermia uses specialized equipment to achieve specific, sustained core temperatures (up to 42°C for WBH) or precise tissue temperatures (up to 44°C for local), with continuous medical monitoring and the ability to maintain target temperatures for defined treatment durations. The therapeutic effects at these higher, controlled temperatures are qualitatively different from those achieved in a sauna.

Determine the Right Hyperthermia Approach for You

Whether you are seeking hyperthermia for cancer treatment, Lyme disease, post-COVID recovery, or another condition, our experienced medical team can determine which type of hyperthermia — or combination — is most appropriate for your specific situation.

Contact us to discuss your treatment options:

• Phone: +49 (0)8061 398-0
• Email: info@clinicum-stgeorg.de
• Visit: Contact page